Can we crack this cancer's immune response?

More than 90% of pancreatic cancer cases are attributed to an aggressive, deadly form of the disease called pancreatic ductal adenocarcinoma, or PDAC. Rese...

November 30, 2023 | Thursday | Reports
GenomOncology's IgniteIQ Advances NLP Pipeline for Cancer Center

Over the last few years, City of Hope has made significant strides in enhancing patient care through their dedicated focus on precision medicine. In an eff...

November 29, 2023 | Wednesday | News
iCAD and GE Healthcare Collaborate to Boost Breast Cancer Detection with AI Solutions

Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...

November 28, 2023 | Tuesday | News
Evaxion Reveals Innovative AI-Immunology™ Cancer Vaccine Concept

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cance...

November 28, 2023 | Tuesday | News
T-Therapeutics Secures £48M in Series A for Advancing Next-Gen TCR Therapeutics in Cancer Treatment Transformation.

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment Fundraise led by Sofin...

November 16, 2023 | Thursday | News
Intelligent Scopes, a Claritas HealthTech Subsidiary, Takes Charge of Global Deployment for CystoSmart™ AI Diagnostic Software in Bladder Cancer Detection

Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in ...

November 13, 2023 | Monday | News
Bayer and Recursion focus research collaboration on Oncology

Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients Drug discovery research coll...

November 10, 2023 | Friday | News
Cancer Drug Parity Act Gains Strong Support from Leading Healthcare Organizations

The International Myeloma Foundation (IMF), which leads the Coalition to Improve Access to Cancer Care (CIACC), fervently supports the Cancer Drug Parity A...

November 09, 2023 | Thursday | News
AdvanCell Initiates Phase I/II TheraPb Trial for Metastatic Prostate Cancer with 212Pb-ADVC001

“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...

November 08, 2023 | Wednesday | News
Senti Bio Collaborates with Celest Therapeutics to Advance SENTI-301A in China

– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 202...

November 07, 2023 | Tuesday | News
Shuttle Pharma Advances Prostate Cancer Biomarker Program via Exclusive License

The intellectual property was originally developed through a collaboration of Shuttle Pharma scientists with investigators from Georgetown University. The ...

November 02, 2023 | Thursday | News
Evaxion Shares Positive Phase 2 Results for Personalized Cancer Vaccine EVX-01

Initial EVX-01 Phase 2 data confirms the strong Phase 1 results After undergoing EVX-01 treatment, a significant and continuous tumor reduction was ...

November 01, 2023 | Wednesday | News
Quantum Leap Initiates Phase 2 DCIS Platform Trial with Atossa, Havah, and Menarini

Quantum Leap Healthcare Collaborative (QLHC) announces the enrollment launch for the Re-Evaluating Conditions for Active Surveillance Suitability as Treatm...

October 31, 2023 | Tuesday | News
Merck Expands Oncology Portfolio with Hengrui Partnership, Promises More Treatment Options for Difficult-to-Treat Cancers

Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...

October 31, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in